AnnaElizabethSchorerMDBoard Certified Clinical Informatics

PubMed

• 2 citations
  Data Sharing to Support the Cancer Journey in the Digital Era
  John C. Krauss, Jeremy L. Warner, Suzanne E. Maddux, Jeffrey R. Brown, Richard Moldwin, Anna E. Schorer, Kevin S. Hughes, Edward P. Ambinder> ;Journal of Oncology Practice. 2016 Jan 12
• 45 citations
  Gynaecomastia and breast cancer in men
  Catherine B. Niewoehner, Anna E. Schorer> ;BMJ. 2008 Mar 27
• 68 citations
  Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.
  Anna E. Schorer, Nicholas Wickham, Kathleen V Watson> ;British Journal of Haematology. 2008 Mar 12
• 5 citations
  Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody.
  Anna E. Schorer> ;Thrombosis Research. 1997 Feb 15
• 5 citations
  Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum.
  Anna E. Schorer, Jasvinder A. Singh, Michael L. Basara> ;American Journal of Hematology. 1995 Nov 1
• 31 citations
  Some antiphospholipid antibodies inhibit phospholipase A2 activity.
  Anna E. Schorer, Peter G. Duane, Virgil L. Woods, Dennis E. Niewoehner> ;The Journal of Laboratory and Clinical Medicine. 1992 Jul 1
• 52 citations
  Lupus anticoagulant inhibition of in Vitro prostacyclin release is associated with a thrombosis-prone subset of patients
  Kathleen V Watson, Anna E. Schorer> ;The American Journal of Medicine. 1991 Jan 1
• 92 citations
  Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells.
  P. J. Shultz, A. E. Schorer, Leopoldo Raij> ;The American Journal of Physiology. 1990 Jan 1
• 28 citations
  Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study.
  Timothy J Wilt, Richard P. Lofgren, Kristin L. Nichol, Anna E. Schorer, Lori Crespin, Deborah Downes, John H. Eckfeldt> ;Annals of Internal Medicine. 1989 Dec 1
• 2 citations
  Interleukin 1 enhances arterial thrombogenicity in vitro.
  Anna E. Schorer, James G. White> ;Thrombosis Research. 1989 Nov 15
• 42 citations
  Endothelial cell heterogeneity: antioxidant profiles determine vulnerability to oxidant injury.
  Gregory M. Vercellotti, Martha Dobson, Anna E. Schorer, Charles F. Moldow> ;Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 1988 Feb 1
• 43 citations
  Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism.
  Anna E. Schorer, Manuel E. Kaplan, Gundu H. R. Rao, Charles F. Moldow> ;Thrombosis and Haemostasis. 1986 Dec 15
• 13 citations
  Acute Respiratory Failure following Severe Arsenic Poisoning
  Charles Greenberg, Scott F. Davies, Anna E. Schorer, Charles W. Drage> ;Chest. 1979 Nov 1
• Platelet-derived growth factor does not stimulate prostacyclin synthesis by cultured endothelial cells.
  Callahan, K. S., Schorer, A., Harlan, J. M.> ;Blood. 1986 Jan
• Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endo...
  Schorer, A. E., Rick, P. D., Swaim, W. R., Moldow, C. F.> ;J Lab Clin Med. 1985 Jul 01
• Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells.
  Schorer, A. E., Moldow, C. F., Rick, M. E.> ;Br J Haematol. 1987 Oct
• Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis.
  Schorer, A. E., Gerrard, J. M., White, J. G., Krivit, W.> ;Prostaglandins Med. 1978 Jul
• Gynecomastia with nitrosourea therapy.
  Schorer, A. E., Oken, M. M., Johnson, G. J.> ;Cancer Treat Rep. 1978 Apr
• Join now to see all